Lesli E Skolarus1, James F Burke2, Lewis B Morgenstern2, William J Meurer2, Eric E Adelman2, Kevin A Kerber2, Brian C Callaghan2, Lynda D Lisabeth2. 1. From the Stroke Program (L.E.S., J.F.B., L.B.M., W.J.M., E.E.A., L.D.L.) and Departments of Neurology (L.E.S., J.F.B., L.B.M., E.E.A., K.A.K., B.C.C.), Epidemiology (L.B.M., L.D.L.), and Emergency Medicine (L.B.M., W.J.M.), University of Michigan, Ann Arbor. lerusche@umich.edu. 2. From the Stroke Program (L.E.S., J.F.B., L.B.M., W.J.M., E.E.A., L.D.L.) and Departments of Neurology (L.E.S., J.F.B., L.B.M., E.E.A., K.A.K., B.C.C.), Epidemiology (L.B.M., L.D.L.), and Emergency Medicine (L.B.M., W.J.M.), University of Michigan, Ann Arbor.
Abstract
BACKGROUND AND PURPOSE: Poststroke rehabilitation is associated with improved outcomes. Medicaid coverage of inpatient rehabilitation facility (IRF) admissions varies by state. We explored the role of state Medicaid IRF coverage on IRF utilization among patients with stroke. METHODS: Working age ischemic stroke patients with Medicaid were identified from the 2010 Nationwide Inpatient Sample. Medicaid coverage of IRFs (yes versus no) was ascertained. Primary outcome was discharge to IRF (versus other discharge destinations). We fit a logistic regression model that included patient demographics, Medicaid coverage, comorbidities, length of stay, tissue-type plasminogen activator use, state Medicaid IRF coverage, and the interaction between patient Medicaid status and state Medicaid IRF coverage while accounting for hospital clustering. RESULTS: Medicaid did not cover IRFs in 4 (TN, TX, SC, WV) of 42 states. The impact of State Medicaid IRF coverage was limited to Medicaid stroke patients (P for interaction <0.01). Compared with Medicaid stroke patients in states with Medicaid IRF coverage, Medicaid stroke patients hospitalized in states without Medicaid IRF coverage were less likely to be discharged to an IRF of 11.6% (95% confidence interval, 8.5%-14.7%) versus 19.5% (95% confidence interval, 18.3%-20.8%), P<0.01 after full adjustment. CONCLUSIONS: State Medicaid coverage of IRFs is associated with IRF utilization among stroke patients with Medicaid. Given the increasing stroke incidence among the working age and Medicaid expansion under the Affordable Care Act, careful attention to state Medicaid policy for poststroke rehabilitation and analysis of its effects on stroke outcome disparities are warranted.
BACKGROUND AND PURPOSE: Poststroke rehabilitation is associated with improved outcomes. Medicaid coverage of inpatient rehabilitation facility (IRF) admissions varies by state. We explored the role of state Medicaid IRF coverage on IRF utilization among patients with stroke. METHODS: Working age ischemic strokepatients with Medicaid were identified from the 2010 Nationwide Inpatient Sample. Medicaid coverage of IRFs (yes versus no) was ascertained. Primary outcome was discharge to IRF (versus other discharge destinations). We fit a logistic regression model that included patient demographics, Medicaid coverage, comorbidities, length of stay, tissue-type plasminogen activator use, state Medicaid IRF coverage, and the interaction between patient Medicaid status and state Medicaid IRF coverage while accounting for hospital clustering. RESULTS: Medicaid did not cover IRFs in 4 (TN, TX, SC, WV) of 42 states. The impact of State Medicaid IRF coverage was limited to Medicaid strokepatients (P for interaction <0.01). Compared with Medicaid strokepatients in states with Medicaid IRF coverage, Medicaid strokepatients hospitalized in states without Medicaid IRF coverage were less likely to be discharged to an IRF of 11.6% (95% confidence interval, 8.5%-14.7%) versus 19.5% (95% confidence interval, 18.3%-20.8%), P<0.01 after full adjustment. CONCLUSIONS: State Medicaid coverage of IRFs is associated with IRF utilization among strokepatients with Medicaid. Given the increasing stroke incidence among the working age and Medicaid expansion under the Affordable Care Act, careful attention to state Medicaid policy for poststroke rehabilitation and analysis of its effects on stroke outcome disparities are warranted.
Authors: A M Kramer; J F Steiner; R E Schlenker; T B Eilertsen; C A Hrincevich; D A Tropea; L A Ahmad; D G Eckhoff Journal: JAMA Date: 1997-02-05 Impact factor: 56.272
Authors: Brett M Kissela; Jane C Khoury; Kathleen Alwell; Charles J Moomaw; Daniel Woo; Opeolu Adeoye; Matthew L Flaherty; Pooja Khatri; Simona Ferioli; Felipe De Los Rios La Rosa; Joseph P Broderick; Dawn O Kleindorfer Journal: Neurology Date: 2012-10-10 Impact factor: 9.910
Authors: Lynda D Lisabeth; Brisa N Sánchez; Jonggyu Baek; Lesli E Skolarus; Melinda A Smith; Nelda Garcia; Devin L Brown; Lewis B Morgenstern Journal: Stroke Date: 2014-03-13 Impact factor: 7.914
Authors: Hormuzdiyar H Dasenbrock; Faith C Robertson; M Ali Aziz-Sultan; Donovan Guittieres; Rose Du; Ian F Dunn; William B Gormley Journal: Neurocrit Care Date: 2016-12 Impact factor: 3.210